| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028182 |
| Receipt No. | R000032253 |
| Official scientific title of the study | The verification study for improving the blood flow: A randomized double-blind placebo-controlled trial |
| Date of disclosure of the study information | 2017/07/11 |
| Last modified on | 2018/07/05 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | The verification study for improving the blood flow: A randomized double-blind placebo-controlled trial | |
| Title of the study (Brief title) | The verification study for improving the blood flow | |
| Region |
|
|
| Condition | |||
| Condition | Healthy Japanese adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To verify the effects of the test food on improving the blood flow |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Blood flow inspection
1. Blood fluidity (MC-FAN) 2. Conditions of the capillaries (Bscan-Z) *1,2 Assess at 0 and 4 weeks after consuming |
| Key secondary outcomes | Questionnaire of subjective symptoms (The Likert scale method)
* Assess at 0 and 4 weeks after consuming |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Duration: 4 weeks
Test materials: Wild herb fermented liquid Administration: Drink a cup of the beverage with a dosing cup (25 mL), once a day at optional timing * Daily dose must be taken within the day. If you forget drinking the beverage, drink it as soon as you remember within the day. |
|
| Interventions/Control_2 | Duration: 4 weeks
Test materials: Placebo Administration: Drink a cup of the beverage with a dosing cup (25 mL), once a day at optional timing * Daily dose must be taken within the day. If you forget drinking the beverage, drink it as soon as you remember within the day. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Healthy Japanese adults
2. Those who are anxious about the results of the recent medical checkup (the values of HbA1c and blood pressure are rather high) 3. Those who are considered as appropriate for the study by the physician 4. Those whose blood fluidity score (smoothness) is "2: caution" or "3: unusual" at screening and examination before ingestion 5. Among the people who passed 4., select those whose blood flow velocity is relatively slow at screening and examination before ingestion |
|||
| Key exclusion criteria | 1. At least one previous medical history or under the treatment of malignant tumor, heart failure or myocardial infarction
2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or other chronic diseases 3. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 4. Currently taking medicines (include herbal medicines) and supplements 5. Those who are allergic to medicines and/or the test food related products 6. Those who have terrible anemia (including currently under the treatment of anemia) 7. Those who drink alcoholic beverages to excess {Average amount of alcohol intake is approximately 60 g per day converted into absolute alcohol (approximately 540 mL of Japanese sake, 3 cans (500 mL / can) of beer, or 300 mL of distilled spirits) } 8. Those who habitually apply medicines to their hands (except for external medicine, moisturizer, and sunscreen) 9. Smokers 10. Those who are chipping off the cuticle on fingernails 11. Those who are pregnant, breast-feeding, and plan to become a pregnant 12. Those who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial 13. Others considered as inappropriate for the study by the physician |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuo YAMAMOTO |
| Organization | ORTHOMEDICO Inc. |
| Division name | CEO |
| Address | 2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo. |
| TEL | 03-3818-0610 |
| kazu@orthomedico.jp | |
| Public contact | |
| Name of contact person | Naoko SUZUKI |
| Organization | ORTHOMEDICO Inc. |
| Division name | R&D Department |
| Address | 2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo. |
| TEL | 03-3818-0610 |
| Homepage URL | |
| nao@orthomedico.jp | |
| Sponsor | |
| Institute | ORTHOMEDICO Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | YASOUKOUSO .Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Seishin-kai Medical Association Inc, Takara Medical Clinic |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人社団 盛心会 タカラクリニック (東京都)
Seishin-kai Medical Association Inc, Takara Medical Clinic (Tokyo) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | Kanai T, Suzuki N, Yamashita S, Takara T. Effects of the Fermented Plant Extract YASOUKOUSO on Blood Flow Rate in Humans-A Randomized, Double-blind, Placebo-controlled Parallel-group Study-. Jpn Pharmacol Ther 2018; 46(6): 1005-1012 |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032253 |